Nobuhiko Emi

Title: Nobuhiko Emi: Innovator in Retroviral Vector Technology

Introduction

Nobuhiko Emi is a notable inventor based in Nagoya, California, who has made significant contributions to the field of biotechnology. His work primarily focuses on the development of retroviral vectors, which are essential tools in gene therapy and molecular biology.

Latest Patents

Nobuhiko Emi holds a patent for "VSV G pseudotyped retroviral vectors." This innovative patent describes an enveloped vector particle that contains gag and pol proteins from a retrovirus, a nucleic acid sequence, and an envelope that includes the VSV G envelope glycoprotein. The vector particle can be utilized to introduce nucleic acids into cells, making it a valuable asset in genetic research and therapeutic applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Nobuhiko Emi has worked with prestigious institutions, including the University of California and Chiron Viagene, Inc. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Nobuhiko Emi has collaborated with esteemed colleagues such as Jiing-Kuan Yee and Theodore Friedmann. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Nobuhiko Emi's contributions to retroviral vector technology highlight his role as a key innovator in biotechnology. His work continues to influence the field and pave the way for future advancements in gene therapy.